CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy

· Second Affiliated Hospital of Guangzhou Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy, covering 2024-06-25 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]